News & Events

Funding boost for cutting-edge health treatments

24 June 2022
Gene therapy

Viral Vector Facility

Kids Research welcomes the NSW government’s funding boost for biomedical research, putting the state at the forefront of cutting-edge health treatments. The Perrottet government has secured $270 million, announced in the state budget, to go towards two new facilities; the Viral Vector manufacturing facility at Westmead and the Sydney Biomedical Accelerator Complex in Camperdown. Premier Domini...

SCHN gene therapy experts speak at global events

21 June 2022
Gene therapy

Gene therapy

World-leading gene therapy experts at Sydney Children’s Hospitals Network (SCHN) have shared their knowledge and experience on a global stage. Researchers, Professor Ian Alexander and Associate Professor Michelle Farrar have spoken at separate conventions in California, after being honoured with an invitation to the events. The pair led the only Australian clinical trial of gene th...

Study confirms COVID-19 cases higher than reported

20 June 2022
COVID-19

COVID-19 study

A new study has found the number of Australian adults infected with COVID-19 at the end of February, was at least twice as high as cases reported to authorities. At least 17 per cent of adults are estimated to have recently been infected with SARS-CoV-2, the virus that causes COVID-19, with the majority of these infections believed to have occurred during the Omicron wave. This result, rele...

World-first treatment changes outlook for SMA babies

18 June 2022
Gene therapy

World-first SMA treatment

Babies diagnosed with Spinal Muscular Atrophy (SMA) at birth who received life-changing gene therapy are now celebrating their first birthday symptom-free or with minimal symptoms thanks to Sydney Children’s Hospitals Network’s (SCHN) world-first clinical trial. The SPR1NT trial, published in the prestigious journal Nature Medicine (two copies of SMN2 and three copies of SMN2), successfull...

News & Events

Addresses

General Enquires

Links

Partners

Address

General Enquires

Links

Partners